Alnylam Pharmaceuticals shares owned by BlackRock
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $4.5B | 9.9M | 456.00 |
| 2025-06-30 | $3.3B | 10M | 326.09 |
| 2025-03-31 | $2.6B | 9.6M | 270.02 |
| 2024-12-31 | $2.3B | 9.9M | 235.31 |
| 2024-09-30 | $2.7B | 9.7M | 275.03 |